Review: The use of functional magnetic resonance imaging (fMRI) in clinical trials and experimental research studies for depression.

Kotoula, Vasileia; Evans, Jennifer W; Punturieri, Claire E; Zarate, Carlos A

Kotoula, Vasileia; Evans, Jennifer W; Punturieri, Claire E; Zarate, Carlos A.

Afiliación

Kotoula V; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Evans JW; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Punturieri CE; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.
Zarate CA; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, United States.

Front Neuroimaging ; 2: 1110258, 2023.

Article en En | MEDLINE | ID: mdl-37554642

Palabras clave

amygdala; clinical trial; depression; functional magnetic resonance imaging (fMRI); ketamine; selective serotonin reuptake inhibitor (SSRI)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Neuroimaging Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google